5-[4-[[4-chloro-2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]-3-methylphenoxy]-2-methoxybenzamide
C24H21ClF3N3O5 — CID 56952743
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-[[4-chloro-2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]-3-methylphenoxy]-2-methoxybenzamide
5-[4-[[4-chloro-2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]-3-methylphenoxy]-2-methoxybenzamide (PubChem CID 56952743) has the molecular formula C24H21ClF3N3O5 and a molecular weight of 523.90 g/mol. Its IUPAC name is 5-[4-[[4-chloro-2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]-3-methylphenoxy]-2-methoxybenzamide.
Molecular Properties
| Compound Name | 5-[4-[[4-chloro-2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]-3-methylphenoxy]-2-methoxybenzamide |
|---|---|
| PubChem CID | 56952743 |
| Molecular Formula | C24H21ClF3N3O5 |
| Molecular Weight | 523.90 g/mol |
| Exact Mass | 523.11 |
| IUPAC Name | 5-[4-[[4-chloro-2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]-3-methylphenoxy]-2-methoxybenzamide |
| SMILES | COc1cc(Cl)c(C(F)(F)F)cc1NC(=O)Nc1ccc(Oc2ccc(OC)c(C(N)=O)c2)cc1C |
| InChI | InChI=1S/C24H21ClF3N3O5/c1-12-8-13(36-14-5-7-20(34-2)15(9-14)22(29)32)4-6-18(12)30-23(33)31-19-10-16(24(26,27)28)17(25)11-21(19)35-3/h4-11H,1-3H3,(H2,29,32)(H2,30,31,33) |
| InChIKey | MZRNMFJKWTVKCF-UHFFFAOYSA-N |
| XLogP | 6.22 |
| TPSA | 111.91 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 523.90 |
| LogP ≤ 5 | 6.22 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 56952743 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.